Navigation Links
Getting close to nature is good for you

Connecting with nature can improve your health and wellbeing, say researchers in this week's BMJ. The theory is known as ecotherapy: restoring health through contact with nature.

Use of wildlife in some therapies is reported to improve quality of life, write the authors. Smaller animals (for example, squirrels, owls, and raccoons) have been used successfully in therapies for children with emotional and behavioural problems.

People who take part in conservation projects report subjective health benefits, ascribed to being outdoors and to feeling part of a greater system connecting beyond the individual. Such projects can help overcome social isolation, develop skills, and improve employment prospects, as well as provide the known benefits associated with exercise.

Although initial research has been promising, the UK needs robust health impact assessments of wildlife projects to determine their objective therapeutic value, say the authors.

English Nature has advocated a national strategy to encourage people to reconnect with nature and benefit from proximity to wildlife.

Partnerships between healthcare providers and nature organisations to share and exchange expertise could create new policies that recognise the interdependence between healthy people and healthy ecosystems, they conclude.


'"/>

Source:BMJ-British Medical Journal


Page: 1

Related biology news :

1. Getting an evolutionary handle on life after reproduction
2. Getting old? Slowing down? Blame inefficient mitochondria
3. Getting to the heart of the heart
4. Chemicals in tattoo inks need closer scrutiny
5. Doctors closer to using gene analysis to help trauma patients
6. Proteomics brings researchers closer to understanding microbes that produce acid mine drainage
7. Computers close in on protein structure prediction
8. New results validating Pall prion reduction filter disclosed at ISBT Congress
9. Scientists closer to new cancer detection method
10. Scientists observe how a close bond activates the immune system
11. Stroke treatment a step closer after trial
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: